Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

67%

2 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 3
2(100.0%)
2Total
Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT03345069Active Not Recruiting

Cincinnati Infant Neurodevelopment Early Prediction Study (CINEPS)

Role: collaborator

NCT00534365Phase 3Completed

Study Comparing TVT With TVT-SECUR for the Treatment of Stress Urinary Incontinence

Role: collaborator

NCT00475839Phase 3Completed

Study Comparing Tension-free Vaginal Tape With the Monarc Procedure for Stress Urinary Incontinence

Role: collaborator

All 3 trials loaded